FDA Supplemental Approval: Blinatumomab for Treatment of...

  • Main
  • 2018 / 07
  • FDA Supplemental Approval: Blinatumomab for Treatment of...
The Oncologist 2018 / 07

FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia

Pulte, E. Dianne, Vallejo, Jonathon, Przepiorka, Donna, Nie, Lei, Farrell, Ann T., Goldberg, Kirsten B., McKee, Amy E., Pazdur, Richard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2018-0179
Date:
July, 2018
File:
PDF, 190 KB
english, 2018
Conversion to is in progress
Conversion to is failed